First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer

Published:2008-10-15 Issue:8 Volume:178 Page:847-853
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Wu Jenn-Yu,Yu Chong-Jen,Yang Chih-Hsin,Wu Shang-Gin,Chiu Yueh-Hsia,Gow Chien-Hung,Chang Yeun-Chung,Hsu Ya-Chieh,Wei Pin-Fei,Shih Jin-Yuan,Yang Pan-Chyr

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference39 articles.

1. Global Cancer Statistics, 2002

2. Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

3. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, Levitan N, Gressot L, Vincent M, Burkes R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.J Clin Oncol2000;18:2095–2103.

4. Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

5. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M,et al.Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.EMBO J1996;15:2452–2467.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining plasma and cerebrospinal fluid concentrations of EGFR-TKI in lung cancer patients;Analytical Biochemistry;2023-05

2. Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case–Control Study;Annals of Surgical Oncology;2022-03-07

3. The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors;Frontiers in Oncology;2022-02-11

4. EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study;Translational Lung Cancer Research;2021-02

5. Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations;Clinical Lung Cancer;2019-11